Lam Research financials
$323.86+2.99%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY26 Jun 28 | FY25 Jun 29 | FY24 Jun 30 | FY23 Jun 25 | FY22 Jun 26 | FY21 Jun 27 | FY20 Jun 28 | FY19 Jun 30 | FY18 Jun 24 | FY17 Jun 25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $23.23B | $18.44B | $14.91B | $17.43B | $17.23B | $14.63B | $10.04B | $9.65B | $11.08B | $8.01B |
| Gross profit | $11.73B | $8.98B | $7.05B | $7.78B | $7.87B | $6.81B | $4.61B | $4.36B | $5.17B | $3.60B |
| Gross margin | 50.5% | 48.7% | 47.3% | 44.6% | 45.7% | 46.5% | 45.9% | 45.1% | 46.6% | 45.0% |
| Operating income | $8.20B | $5.90B | $4.26B | $5.17B | $5.38B | $4.48B | $2.67B | $2.46B | $3.21B | $1.90B |
| Net income | $7.27B | $5.36B | $3.83B | $4.51B | $4.61B | $3.91B | $2.25B | $2.19B | $2.38B | $1.70B |
| Net margin | 31.3% | 29.1% | 25.7% | 25.9% | 26.7% | 26.7% | 22.4% | 22.7% | 21.5% | 21.2% |
| Diluted EPS | $5.76 | $4.15 | $2.90 | $3.32 | $3.27 | $2.69 | $1.51 | $1.37 | $1.32 | $0.92 |
| EBITDA | $8.64B | $6.29B | $4.64B | $5.56B | $5.72B | $4.79B | $2.94B | $2.77B | $3.54B | $2.21B |
| Operating cash flow | $5.86B | $6.17B | $4.65B | $5.18B | $3.10B | $3.59B | $2.13B | $3.18B | $2.66B | $2.03B |
| Free cash flow | $4.89B | $5.41B | $4.26B | $4.68B | $2.55B | $3.24B | $1.92B | $2.87B | $2.38B | $1.87B |
| Diluted shares | 1,261.1M | 1,290.1M | 1,319.9M | 1,358.3M | 1,406.3M | 1,453.2M | 1,490.9M | 1,599.2M | 1,807.8M | 1,837.7M |
Balance sheet
| Period end | Jun 28 | Jun 29 | Jun 30 | Jun 25 | Jun 26 | Jun 27 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $5.58B | $6.39B | $5.85B | $5.34B | $3.52B | $4.42B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $135.7M | $1.31B |
| Total debt | $3.73B | $4.48B | $4.98B | $5.01B | $5.01B | $5.00B |
| Total assets | $23.53B | $21.35B | $18.74B | $18.78B | $17.20B | $15.89B |
| Total liabilities | $11.06B | $11.48B | $10.21B | $10.57B | $10.92B | $9.86B |
| Shareholders' equity | $12.47B | $9.86B | $8.54B | $8.21B | $6.28B | $6.03B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology